Dr Reddys Laboratories Launches Sorafenib Tablets In Uk Market
Dr Reddy'S Sorafenib Tablets, Usp, Are Available In 200 Mg Tablets In Bottle Count Sizes Of 120 And Are Used In The Treatment Of Liver, Kidney And Thyroid Cancer. Ney And Thyroid Cancer.Dr Reddy'S Laboratories On Tuesday Said It Has Launched Sorafenib Tablets, Used In The Treatment Of Various Cancers, In The Us Market After Getting Approval From The Us Food And Drug Administration (Usfda). "We Are Pleased To Launch This Important Generic Product, Illustrating Our Continued Commitment To Bring Affordable Generic Medicines To Market For Patients," Dr Reddy'S Laboratories Inc North America Generics Ceo Marc Kikuchi Said In A Statement. Dr Reddy'S Sorafenib Tablets, Usp, Are Available In 200 Mg Tablets In Bottle Count Sizes Of 120 And Are Used In The Treatment Of Liver, Kidney And Thyroid Cancer. The Company'S Product Is A Therapeutic Generic Equivalent Of Bayer Healthcare Pharmaceuticals Inc'S Nexavar Tablets.

Optimize Your trial insights with Clival Database.
Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.
With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.
To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.
Elevate your trial success rate with the cutting-edge insights from Clival database.
Check it out today and make more informed sourcing decisions! Learn More!